Product Information

BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Padagis US LLC, priced at $0.0804 per ML under NDC 00574110404. Its NADAC has been published 598 times since Mar 11, 2015.

FDA first approved this application on Jul 15, 2014. Its Orange Book therapeutic-equivalence code is AA.

Strength

2; 10; 30 mg/5mL; mg/5mL; mg/5mL

Manufacturer

Padagis US LLC

NDC

00574110404

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205292

FDA Approved

7/15/2014

TE Code

AA

On Market Since

2/6/2015

Pharmacological Classes

Adrenergic alpha-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 598 times since Mar 11, 2015, and over the history we have for it it has declined 55.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0804 per ML
All-time high$0.1855 (Aug 12, 2015)
All-time low$0.0594 (Apr 17, 2024)
52-week high$0.0868
52-week low$0.0744
Median price$0.0930
Average price$0.1092
Largest weekly change+60.3% (Nov 22, 2023)
Weeks tracked598
Tracking sinceMar 11, 2015

Price History

1W

-2.5%

1M

-2.5%

3M

+8.0%

6M

+4.6%

1Y

+0.8%

3Y

+1.9%

5Y

-5.0%

All

-55.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 11%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Padagis US LLC, is $0.0804 per ML (NDC 00574110404), effective Aug 19, 2026.

How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?

Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has declined 55.3%. It has been tracked across 598 weekly CMS publications since Mar 11, 2015.

What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Since Mar 11, 2015, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0594 (Apr 17, 2024) to a high of $0.1855 (Aug 12, 2015), with a median of $0.0930 per ML.

Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMPHEN-PSE-DM 2-30-10 MG/5 ML, is $0.0714 per ML — about 11% below BROMPHEN-PSE-DM 2-30-10 MG/5 ML.

Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?

BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 00574110404) is labeled by Padagis US LLC, and CMS classifies it as a generic product.